Journal Of Clinical Oncology (jco) Podcast
Deciphering the Heterogeneity Within EGFR-mutant Lung Cancer
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:06:54
- Mas informaciones
Informações:
Sinopsis
A meta-analysis of 7 randomized trials comparing EGFR kinase inhibitors to chemotherapy for advanced EGFR-mutant lung cancer has shown that some populations gain greater benefit from targeted therapy – namely never-smokers, woman, and tumor harboring exon 19 deletions.
